Tearsheet

Addus HomeCare (ADUS)


Market Price (12/4/2025): $117.86 | Market Cap: $2.1 Bil
Sector: Health Care | Industry: Health Care Services

Addus HomeCare (ADUS)


Market Price (12/4/2025): $117.86
Market Cap: $2.1 Bil
Sector: Health Care
Industry: Health Care Services

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Low stock price volatility
Vol 12M is 32%
Weak multi-year price returns
2Y Excs Rtn is -16%, 3Y Excs Rtn is -64%
Expensive valuation multiples
P/EPrice/Earnings or Price/(Net Income) is 25x
1 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Remote Patient Monitoring, Show more.
  
0 Low stock price volatility
Vol 12M is 32%
1 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Remote Patient Monitoring, Show more.
2 Weak multi-year price returns
2Y Excs Rtn is -16%, 3Y Excs Rtn is -64%
3 Expensive valuation multiples
P/EPrice/Earnings or Price/(Net Income) is 25x

Valuation, Metrics & Events

ADUS Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

Here are the key points influencing Addus HomeCare's (ADUS) stock performance from August 31, 2025, to December 4, 2025: 1. Strong Third Quarter 2025 Financial Results. Addus HomeCare announced robust financial results for the third quarter ended September 30, 2025, on November 3, 2025. The company reported a 25.0% increase in net service revenues to $362.3 million, surpassing analyst estimates, and adjusted diluted earnings per share (EPS) of $1.56, which also exceeded expectations and represented a 20.0% year-over-year increase.

2. Continued Strategic Acquisitions. Addus HomeCare reinforced its growth strategy through acquisitions within the period. Notably, the company completed the acquisition of Helping Hands Home Care on August 1, 2025, and the Del Cielo acquisition on October 1, 2025. These strategic moves expand its market reach and service offerings.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
ADUS Return20%-20%6%-7%35%-4%24%
Peers Return18%14%-4%18%-14%70%124%
S&P 500 Return16%27%-19%24%23%16%112%

Monthly Win Rates [3]
ADUS Win Rate58%33%50%50%67%60% 
Peers Win Rate37%45%37%35%43%64% 
S&P 500 Win Rate58%75%42%67%75%70% 

Max Drawdowns [4]
ADUS Max Drawdown-50%-37%-25%-21%-7%-28% 
Peers Max Drawdown-38%-14%-27%-21%-24%-18% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: BTSG, BKD, VRDN, USPH, CVS. See ADUS Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/3/2025 (YTD)

How Low Can It Go

Unique KeyEventADUSS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-44.9%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven81.5%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven902 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-53.4%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven114.5%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven219 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-23.1%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven30.0%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven154 days120 days

Compare to BTSG, BKD, VRDN, USPH, CVS


In The Past

Addus HomeCare's stock fell -44.9% during the 2022 Inflation Shock from a high on 1/22/2021. A -44.9% loss requires a 81.5% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Addus HomeCare (ADUS)

Better Bets than Addus HomeCare (ADUS)

Trade Ideas

Select past ideas related to ADUS. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
4.1%4.1%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-9.8%-9.8%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
6.0%6.0%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
9.7%9.7%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
6.2%6.2%-5.1%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
4.1%4.1%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-9.8%-9.8%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
6.0%6.0%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
9.7%9.7%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
6.2%6.2%-5.1%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Addus HomeCare

Peers to compare with:

Financials

ADUSBTSGBKDVRDNUSPHCVSMedian
NameAddus Ho.BrightSp.Brookdal.Viridian.US Physi.CVS Heal. 
Mkt Price117.8935.1210.6131.3075.4175.0055.06
Mkt Cap2.17.12.52.61.195.22.5
Rev LTM1,34713,3013,22171759394,0842,284
Op Inc LTM12334164-3287510,75199
FCF LTM9627641-326576,29377
FCF 3Y Avg10755-52-235656,42760
CFO LTM103349229-326709,109166
CFO 3Y Avg115132155-234759,277124

Growth & Margins

ADUSBTSGBKDVRDNUSPHCVSMedian
NameAddus Ho.BrightSp.Brookdal.Viridian.US Physi.CVS Heal. 
Rev Chg LTM18.8%37.1%3.9%23,340.1%17.5%6.8%18.1%
Rev Chg 3Y Avg13.3%24.3%6.2%7,748.5%11.9%7.7%12.6%
Rev Chg Q25.0%28.2%3.7%81,958.1%17.3%7.8%21.2%
QoQ Delta Rev Chg LTM5.7%5.8%0.9%23,109.5%4.0%1.9%4.8%
Op Mgn LTM9.2%2.6%2.0%-463.5%9.9%2.7%2.6%
Op Mgn 3Y Avg8.8%1.8%1.1%-53,685.3%10.6%3.3%2.5%
QoQ Delta Op Mgn LTM0.0%0.3%0.0%121,367.6%0.2%0.1%0.2%
CFO/Rev LTM7.7%2.6%7.1%-460.5%9.2%2.3%4.9%
CFO/Rev 3Y Avg10.0%1.0%4.9%-39,207.4%11.4%2.5%3.7%
FCF/Rev LTM7.2%2.1%1.3%-461.0%7.5%1.6%1.8%
FCF/Rev 3Y Avg9.2%0.3%-1.8%-39,349.1%9.9%1.8%1.0%

Valuation

ADUSBTSGBKDVRDNUSPHCVSMedian
NameAddus Ho.BrightSp.Brookdal.Viridian.US Physi.CVS Heal. 
Mkt Cap2.17.12.52.61.195.22.5
P/S1.60.50.624.91.70.21.1
P/EBIT16.817.6-34.8-5.914.316.015.1
P/E24.946.4-6.6-5.839.1204.032.0
P/CFO20.717.28.8-5.418.610.513.9
Total Yield4.0%2.2%-15.2%-17.1%3.6%4.0%2.9%
Dividend Yield0.0%0.0%0.0%0.0%1.0%3.5%0.0%
FCF Yield 3Y Avg5.6%--5.5%-19.5%4.9%7.1%4.9%
D/E0.10.42.70.00.20.90.3
Net D/E0.00.42.6-0.30.20.70.3

Returns

ADUSBTSGBKDVRDNUSPHCVSMedian
NameAddus Ho.BrightSp.Brookdal.Viridian.US Physi.CVS Heal. 
1M Rtn-0.9%4.9%15.7%35.2%-12.7%-4.4%2.0%
3M Rtn4.2%45.8%39.1%60.8%-9.4%3.1%21.6%
6M Rtn5.2%48.9%60.3%121.2%2.0%20.2%34.6%
12M Rtn-3.5%85.0%92.6%55.8%-22.0%32.1%44.0%
3Y Rtn4.7%-217.7%13.8%-11.9%-18.0%4.7%
1M Excs Rtn-0.9%4.9%15.7%35.2%-12.7%-4.4%2.0%
3M Excs Rtn0.1%40.4%33.3%62.6%-16.9%-2.7%16.7%
6M Excs Rtn-9.5%34.2%45.6%106.5%-12.7%5.5%19.9%
12M Excs Rtn-17.6%68.4%73.2%31.7%-35.4%17.1%24.4%
3Y Excs Rtn-63.8%-189.3%-34.4%-76.1%-89.0%-63.8%

Financials

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Personal Care795707686647581
Hospice20720215210154
Home Health5743261614
Total1,059951864765649


Operating Income by Segment
$ Mil20242023202220212020
Personal Care15812512210791
Hospice4551422914
Home Health73311
Depreciation and amortization-14-14-14-12-11
Other general and administrative expenses-104-96-88-80-61
Total9169664535


Price Behavior

Short Interest

Short Interest: As Of Date11142025
Short Interest: Shares Quantity678,868
Short Interest: % Change Since 103120259.5%
Average Daily Volume231,839
Days-to-Cover Short Interest2.93
Basic Shares Quantity18,072,000
Short % of Basic Shares3.8%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251104202510-Q 9/30/2025
6302025805202510-Q 6/30/2025
3312025506202510-Q 3/31/2025
12312024225202510-K 12/31/2024
93020241105202410-Q 9/30/2024
6302024806202410-Q 6/30/2024
3312024507202410-Q 3/31/2024
12312023227202410-K 12/31/2023
93020231031202310-Q 9/30/2023
6302023801202310-Q 6/30/2023
3312023502202310-Q 3/31/2023
12312022228202310-K 12/31/2022
93020221101202210-Q 9/30/2022
6302022802202210-Q 6/30/2022
3312022503202210-Q 3/31/2022
12312021225202210-K 12/31/2021